Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
Cleveland Clinic Foundation - Ohio
2033
mi
from 91732
Cleveland, OH
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
Cleveland Clinic Foundation - Ohio
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
University of Oklahoma
1165
mi
from 91732
Oklahoma City, OK
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
University of Oklahoma
1165
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
Womens Hospital of Texas
1358
mi
from 91732
Houston, TX
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
Womens Hospital of Texas
1358
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
Sacred Heart Medical Center
938
mi
from 91732
Spokane, WA
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
Sacred Heart Medical Center
938
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
St. Lukes Hospital
828
mi
from 91732
Allentown, PA
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
St. Lukes Hospital
828
mi
from 91732
Allentown, PA
Click here to add this to my saved trials
Comparing Oxygen Saturation in Post Anesthesia Care Unit After Different Methods of Pain Relief
Oxygen Saturation During Transfer From Operating Room to Post Anesthesia Care Unit After Current Anesthesia Care
Status: Enrolling
Updated:  12/11/2015
University of Texas,Anesthesiology Department
1357
mi
from 91732
Houston, TX
Comparing Oxygen Saturation in Post Anesthesia Care Unit After Different Methods of Pain Relief
Oxygen Saturation During Transfer From Operating Room to Post Anesthesia Care Unit After Current Anesthesia Care
Status: Enrolling
Updated: 12/11/2015
University of Texas,Anesthesiology Department
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Status: Enrolling
Updated:  12/14/2015
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Status: Enrolling
Updated: 12/14/2015
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1784
mi
from 91732
Birmingham, AL
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
328
mi
from 91732
Stanford, CA
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
2148
mi
from 91732
Sarasota, FL
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
2148
mi
from 91732
Sarasota, FL
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
2130
mi
from 91732
St. Petersburg, FL
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
2130
mi
from 91732
St. Petersburg, FL
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
664
mi
from 91732
Meridian, ID
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
664
mi
from 91732
Meridian, ID
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1339
mi
from 91732
Kansas City, KA
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1339
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1840
mi
from 91732
Grand Rapids, MI
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1840
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1897
mi
from 91732
Jackson, MI
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1897
mi
from 91732
Jackson, MI
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1501
mi
from 91732
Plymouth, MN
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1501
mi
from 91732
Plymouth, MN
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1569
mi
from 91732
Woodbury, MN
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1569
mi
from 91732
Woodbury, MN
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
2430
mi
from 91732
Brick, NJ
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
2430
mi
from 91732
Brick, NJ
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1959
mi
from 91732
Columbus, OH
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1204
mi
from 91732
Arlington, TX
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1204
mi
from 91732
Arlington, TX
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1216
mi
from 91732
Carrolton, TX
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1216
mi
from 91732
Carrolton, TX
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
1218
mi
from 91732
Temple, TX
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
1218
mi
from 91732
Temple, TX
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Alliance Urology Specialists
2151
mi
from 91732
Greensboro, NC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Alliance Urology Specialists
2151
mi
from 91732
Greensboro, NC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Carolina Urologic Research Center
2234
mi
from 91732
Myrtle Beach, SC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Carolina Urologic Research Center
2234
mi
from 91732
Myrtle Beach, SC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Citrus Valley Medical Research, Inc.
9
mi
from 91732
Glendora, CA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Citrus Valley Medical Research, Inc.
9
mi
from 91732
Glendora, CA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Female Pelvic Medicine & Urogynecology Institute of MI
1843
mi
from 91732
Grand Rapids, MI
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Female Pelvic Medicine & Urogynecology Institute of MI
1843
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
MetroHealth Med Ctr
2032
mi
from 91732
Cleveland, OH
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
MetroHealth Med Ctr
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Premier Medical Group of the Hudson Valley
2433
mi
from 91732
Poughkeepsie, NY
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Premier Medical Group of the Hudson Valley
2433
mi
from 91732
Poughkeepsie, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Premier Medical Group of the Hudson Valley PC
2429
mi
from 91732
Newburgh, NY
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Premier Medical Group of the Hudson Valley PC
2429
mi
from 91732
Newburgh, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
The UrogynecologyCenter, LLC
1335
mi
from 91732
Overland Park, KA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
The UrogynecologyCenter, LLC
1335
mi
from 91732
Overland Park, KA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Volunteer Research Group, University of Tennessee Medical Center
1923
mi
from 91732
Knoxville, TN
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Volunteer Research Group, University of Tennessee Medical Center
1923
mi
from 91732
Knoxville, TN
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Wake Forest Baptist Health
2126
mi
from 91732
Winston-Salem, NC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Wake Forest Baptist Health
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
William Beaumont Hospitals
1962
mi
from 91732
Royal Oak, MI
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
William Beaumont Hospitals
1962
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Atlantic Urological Associates
2187
mi
from 91732
Daytona Beach, FL
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Atlantic Urological Associates
2187
mi
from 91732
Daytona Beach, FL
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
North Shore - Long Island Jewish Heath System - Monter Cancer Center
2449
mi
from 91732
New Hyde Park, NY
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
North Shore - Long Island Jewish Heath System - Monter Cancer Center
2449
mi
from 91732
New Hyde Park, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Exdeo Clinical Research Inc.
1058
mi
from 91732
Abbotsford,
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Exdeo Clinical Research Inc.
1058
mi
from 91732
Abbotsford,
Click here to add this to my saved trials
Urology Database to Evaluate Clinical Information and Improve Patient Care.
Urology Database for Outcomes Research
Status: Enrolling
Updated:  12/22/2015
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Urology Database to Evaluate Clinical Information and Improve Patient Care.
Urology Database for Outcomes Research
Status: Enrolling
Updated: 12/22/2015
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated:  12/29/2015
Hartford Hospital, Urogynecology Division
2504
mi
from 91732
Glastonbury, CT
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated: 12/29/2015
Hartford Hospital, Urogynecology Division
2504
mi
from 91732
Glastonbury, CT
Click here to add this to my saved trials
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated:  12/29/2015
Hartford Hospital, Urogynecology Division
2496
mi
from 91732
Hartford, CT
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated: 12/29/2015
Hartford Hospital, Urogynecology Division
2496
mi
from 91732
Hartford, CT
Click here to add this to my saved trials
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated:  12/29/2015
Hartford Hospital, Urogynecology Division
2494
mi
from 91732
West Hartford, CT
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated: 12/29/2015
Hartford Hospital, Urogynecology Division
2494
mi
from 91732
West Hartford, CT
Click here to add this to my saved trials
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Status: Enrolling
Updated:  1/5/2016
Oakland University
1964
mi
from 91732
Rochester, MI
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Status: Enrolling
Updated: 1/5/2016
Oakland University
1964
mi
from 91732
Rochester, MI
Click here to add this to my saved trials
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Status: Enrolling
Updated:  1/5/2016
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Status: Enrolling
Updated: 1/5/2016
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Further Enhancing Non-pharmacologic Therapy for Incontinence
Further Enhancing Non-pharmacologic Therapy for Incontinence
Status: Enrolling
Updated:  1/7/2016
Geriatric Continence Research Unit, NE547 Montefiore UPMC
2121
mi
from 91732
Pittsburgh, PA
Further Enhancing Non-pharmacologic Therapy for Incontinence
Further Enhancing Non-pharmacologic Therapy for Incontinence
Status: Enrolling
Updated: 1/7/2016
Geriatric Continence Research Unit, NE547 Montefiore UPMC
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
Assessing the Impact of Low-Touch Devices on Medication Adherence
Status: Enrolling
Updated:  1/7/2016
CVS Health
2556
mi
from 91732
Woonsocket, RI
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
Assessing the Impact of Low-Touch Devices on Medication Adherence
Status: Enrolling
Updated: 1/7/2016
CVS Health
2556
mi
from 91732
Woonsocket, RI
Click here to add this to my saved trials